Log in

Primary transplantation of allogeneic peripheral blood stem cell for severe aplastic anemia

  • CASE REPORT
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

 Primary allogeneic peripheral blood stem cell transplantation (allo-PBSCT) has not been previously described in the treatment of severe aplastic anemia (SAA). We report a patient with SAA who underwent primary allo-PBSCT with cells from her HLA-identical sibling and achieved rapid bone marrow reconstitution. The patient has been in complete remission with normal blood counts for 9 months following allo-PBSCT. This suggests that primary allo-PBSCT is a safe and effective alternative in the treatment of SAA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 13 November 1996 / Accepted: 29 January 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hsu, H., Tsai, W., Lin, J. et al. Primary transplantation of allogeneic peripheral blood stem cell for severe aplastic anemia. Ann Hematol 74, 191–192 (1997). https://doi.org/10.1007/s002770050281

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002770050281

Navigation